For the Inventor, By the Inventor

Enter assignee name

Agoura Hills, CA, United States of America

A2 Biotherapeutics, Inc.

USPTO Granted Patents = 13

EPO Patents = 1

Trademarks = 5

Forward Citations = 11

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Carl Alexander Kamb (9 out of 9 patents)

Agnes Eva Hamburger (5 out of 35 patents)

Breanna Diandreth (4 out of 4 patents)

4. Mark E Daris (4 out of 7 patents)

5. Kiran Deshmukh (4 out of 4 patents)

6. Han Xu (4 out of 4 patents)

7. Alexander Kamb (4 out of 4 patents)

8. Dora Toledo Warshaviak (3 out of 3 patents)

9. Xueyin Wang (2 out of 2 patents)

10. Mark L Sandberg (2 out of 2 patents)

11. Julyun Oh (2 out of 2 patents)

12. Talar Tokatlian (1 out of 1 patent)

13. Yuta Ando (1 out of 1 patent)

13 patents: Sort by Forward Citations

1. 12459983 - Engineered immune cells with receptor signal strength modulated by a hinge (2025-11-04),

2. 12435124 - Compositions and methods for treating CEACAM positive cancers (2025-10-07),

3. 12215134 - Engineered immune cells with dominant signals (2025-02-04),

4. 12195513 - LILRB1-based chimeric antigen receptor (2025-01-14),

5. 12187775 - LILRB1-based chimeric antigen receptor (2025-01-07),

6. 12037377 - LILRB1-based chimeric antigen receptor (2024-07-16),

7. 12012612 - Engineered immune cells with receptor signal strength modulated by a hinge (2024-06-18),

8. 11976297 - Engineered immune cells with receptor cross-talk (2024-05-07),

9. 11730764 - Compositions and methods for treating HER2 positive cancers (2023-08-22),

10. 11602544 - Compositions and methods for treating EGFR positive cancers (2023-03-14),

11. 11602543 - Compositions and methods for treating mesothelin positive cancers (2023-03-14),

12. 11433100 - Compositions and methods for treating ceacam positive cancers (2022-09-06),

13. 11254726 - LILRB1-based chimeric antigen receptor (2022-02-22),

A2 Biotherapeutics, Inc. is a leading biotechnology company focused on developing innovative cell therapies for cancer treatment. Using its proprietary platform, A2 Biotherapeutics is able to engineer immune cells to target and destroy cancer cells with precision. The company's mission is to harness the power of the immune system to fight cancer and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

13 Patents

#3 in Agoura Hills, CA

#5,472 in California

#23,099 in US

#43,615 in the World

Agoura Hills, CA, United States of America

A2 Biotherapeutics, Inc.

Forward Citations = 11

13 inventors:

Carl Alexander Kamb (9 out of 9 patents)

Agnes Eva Hamburger (5 out of 35 patents)

Breanna Diandreth (4 out of 4 patents)

4. Mark E Daris (4 out of 7 patents)

5. Kiran Deshmukh (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…